Results 41 to 50 of about 226,373 (256)

Stereotactic radiotherapy for bone oligometastases

Reports of Practical Oncology and Radiotherapy, 2022
About 60-90% of cancer patients are estimated to develop bone metastases, particularly in the spine. Bone scintigraphy, computed tomography (CT ) and magnetic resonance imaging (MRI ) are currently used to assess metastatic bone disease; positron emission tomography/computed tomography (PET-CT ) has become more widespread in clinical practice because ...
Colosimo C., Pasqualetti F., Aristei C., Borghesi S., Forte L., Mignogna M., Badii D., Bosio M., Paiar F., Nanni S., Bertocci S., Lastrucci L., Parisi S., Ingrosso G.   +13 more
openaire   +3 more sources

Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?

Clinical and Translational Radiation Oncology, 2019
Renal cell carcinoma (RCC) has traditionally been regarded as radioresistant tumor based on preclinical data and negative clinical trials using conventional fractionated radiotherapy. However, there is emerging evidence that radiotherapy delivered in few
Alexander Rühle, Nicolaus Andratschke, Shankar Siva, Matthias Guckenberger   +3 more
doaj   +1 more source

Re-irradiation: Outcome, cumulative dose and toxicity in patients retreated with stereotactic radiotherapy in the abdominal or pelvic region [PDF]

, 2012
The purpose of the present study was to explore the outcome, cumulative dose in tumor and organs at risk and toxicity after extra-cranial stereotactic re-irradiation.
Hoogeman, M.S. (Mischa), Nuyttens, J.J.M.E. (Joost), Nuyttens, J.J.M.E., Hoogeman, M, Abusaris, H. (Huda), Abusaris, Huda   +5 more
core   +2 more sources

Radiation optic neuropathy and retinopathy in patients with presumed benign intraorbital tumours treated with fractionated stereotactic radiotherapy

, 2022
Purpose: To assess the long-term effects of fractionated stereotactic radiotherapy (fSRT) for the treatment of (presumed) benign intraorbital tumours on visual acuity, visual fields, globe and eyelid position, and complications including radiation ...
Paridaens, D.; id_orcid, S. E. Detiger, D. Paridaens, de Keizer, R. O.B., O. Gishti, C. van Rij, C. Slagter, Detiger, S. E., Slagter, C., Gishti, O., van Rij, C., R. O. B. de Keizer, Paridaens, D.   +12 more
core   +1 more source

Radiotherapy management of brain metastases using conventional linear accelerator

Biomedical Papers, 2016
Background and Aims: As treatments for primary cancers continue to improve life expectancy, unfortunately, brain metastases also appear to be constantly increasing and life expectancy for patients with brain metastases is low.
Marcel Matzenauer, David Vrana, Zuzana Vlachova, Karel Cwiertka, Ondrej Kalita, Bohuslav Melichar   +5 more
doaj   +1 more source

Stereotactic Radiotherapy in Uveal Melanoma

, 2014
Uveal melanoma is the most common primary malignant intraocular neoplasm in adults. The aims of treatment of the uveal melanoma are to prevent the metastatic spread of the disease and to preserve as much useful vision as possible.
Ela Delikgöz Soykut, Yıldız Yükselen Güney, Ayşen Dizman   +2 more
core   +1 more source

Stereotactic Body Radiotherapy

, 2017
Stereotactic body radiation therapy (SBRT) consists of the delivery of precise, conformal, hypofractionated, and ablative therapy in a single or a small number of fractions to extracranial regions. Over the last decade, it is rapidly being integrated into mainstream radiation oncology practices.
Kothari, Gargi, Lo, Simon S., Foote, Matthew, Sahgal, Arjun, Karam, Irene, Lock, Michael, Blom, Gerrit J., Guckenberger, Matthias, Slotman, Ben J., Siva, Shankar   +9 more
openaire   +3 more sources

Stereotactic body radiotherapy for oligometastases

The Lancet Oncology, 2013
The management of metastatic solid tumours has historically focused on systemic treatment given with palliative intent. However, radical surgical treatment of oligometastases is now common practice in some settings. The development of stereotactic body radiotherapy (SBRT), building on improvements in delivery achieved by intensity-modulated and image ...
Tree, A, Khoo, V, Eeles, R, Ahmed, M, Dearnaley, D, Hawkins, M, Huddart, R, Nutting, C, Ostler, P, van As, N   +9 more
openaire   +3 more sources

Stereotactic multiple arc radiotherapy

The British Journal of Radiology, 1990
Abstract A radiotherapy technique is presented for delivering a concentrated pattern of absorbed dose to intracranial lesions. Treatment takes place on a conventional, isocentrically mounted linear accelerator, rotated in several planes around a single target site.
E S, Thomson, S S, Gill, D, Doughty
openaire   +2 more sources

Stereotactic radiotherapy for brain oligometastases

Reports of Practical Oncology and Radiotherapy, 2022
Brain metastases, the most common metastases in adults, will develop in up to 40% of cancer patients, accounting for more than one-half of all intracranial tumors. They are most associated with breast and lung cancer, melanoma and, less frequently, colorectal and kidney carcinoma. Magnetic resonance imaging (MRI) is the gold standard for diagnosis. For
Lupattelli M., Tini P., Nardone V., Aristei C., Borghesi S., Maranzano E., Anselmo P., Ingrosso G., Deantonio L., di Monale e Bastia M. B.   +9 more
openaire   +7 more sources